Competitive Analysis of Shift-Worker Nutrition Product Market

Key Players

Competitive Landscape

Companies in this market compete on features a buyer can easily check. A label dose can be read, an NSF/ANSI 173 listing can be looked up and a format can be seen on a shelf or in an online basket. OLLY's listing spans sleep gummies, a sleep softgel and tablet, daily energy gummies and a probiotic-prebiotic gummy, meaning one brand covers sleep, energy and gut-support formats in a single certified listing. Thorne's listing takes another route, offering electrolyte stick packs and a magnesium capsule listed as a sleep aid.

Investment follows a different logic. Pharmavite's 2025 New Albany facility adds manufacturing and R&D capacity in the USA, which gives the company significant room to develop new formulations and formats.

Policy and company developments mapped to drivers, trends and opportunities (2025 to 2026)

Table 7: Developments mapped to demand drivers, trends and opportunities for the Shift-Worker Nutrition Product Market (descriptive), 2025 to 2026

Development Driver Trend Opportunity
Pharmavite, maker of Nature Made: 2025 opening of a USD 250 Million, 225,000 square foot manufacturing and R&D facility in New Albany, Ohio (City of New Albany, 2025 Annual Report, published 2026). Supply and development capacity for US supplement demand. Manufacturing and R&D investment alongside established brand ranges. Resources for formulation development and scaled production.
South Korea Ministry of Employment and Labor, June 29, 2026: health support for night workers at workplaces with fewer than 300 employees. Attention to rotation, consecutive nights, breaks, naps and rest facilities at high-risk workplaces. Health consultation, sleep and fatigue assessment and clinic referral through worker health centers; overwork prevention centers planned for 2027. Greater attention to sleep and fatigue at smaller high-risk workplaces.
Safe Work Australia, September 19, 2025: model code of practice on managing the risk of fatigue at work. Organizational fatigue controls as the primary response to fatigue. Caffeine treated as a temporary reducer of felt fatigue and not as a control. Alertness claims need to stay clear of fatigue control. Adoption of the model code varies by jurisdiction.

Source: public sources identified in Research Sources and Bibliography.

Pharmavite's investment adds supply capacity, while the Korean and Australian items strengthen structural responses to night work that do not involve buying a product. Spending on products grows where those structural responses leave a gap and shrinks where they successfully close it.

How do the profiled companies differ in positioning?

OLLY (Unilever)'s NSF/ANSI 173 listing spans sleep, energy and probiotic-prebiotic gummies, a softgel and a tablet. Thorne's listing includes electrolyte stick packs and a magnesium capsule listed as a sleep aid. Pharmavite (Nature Made) is documented through its 2025 manufacturing and R&D facility. Natrol, Ritual, NOW Health Group, and Nuun (Nestle Health Science) complete the roster.

What should buyers check before choosing a shift-worker product?

Four checks apply. The dose and form on the label come first. Independent testing, such as an NSF/ANSI 173 listing, comes second, and it covers listed products rather than clinical benefit. Third is whether the ingredient is permitted and which claims are allowed in the buyer's specific country. Fourth is the time of use, since drowsiness can severely affect driving and machinery work.

Which products fall outside the market boundary?

Prescription melatonin, ordinary coffee and meals, and employer fatigue-management services are alternatives and not market revenue. Prescription melatonin in the UK and the medicine-only ingredient classification in Japan keep those products outside the supplement count, and meal planning, water and caffeine timing advice describes practices that cost little and actively compete for the same physiological need.

Representative Company Overview

Table 8: Representative company overview for the Shift-Worker Nutrition Product Market (descriptive), 2025 to 2026

Company Positioning Dated fact
OLLY (Unilever) Gummy-led sleep, energy and probiotic-prebiotic formats, with a sleep softgel and a sleep tablet, under one NSF/ANSI 173 listing. NSF/ANSI 173 listing, accessed October 9, 2026.
Thorne Electrolyte stick packs and a magnesium glycinate capsule listed as a sleep aid under NSF/ANSI 173. NSF/ANSI 173 listing, accessed October 9, 2026.
Pharmavite (Nature Made) US manufacturing and R&D investment by the maker of Nature Made. 2025: USD 250 Million facility of 225,000 square feet in New Albany, Ohio, creating 225 jobs.

Research Methodology

FMI estimates for 2026 to 2036 cover the segments, regions and five profiled countries listed in the report scope. Public context comes from government agencies, public institutions, a peer-reviewed journal, nonprofit certifiers and a municipal annual report, each cited with its own publication date. Where a publication date and a data year differ, both are shown, and findings are kept strictly at the scope of the source: a certification listing covers listed products, a laboratory study covers its laboratory conditions, and a workforce count covers its own specific definition of night work.

Future Market Insights

Shift-Worker Nutrition Product Market